Press Release – BLIS Technologies
BLIS Technologies Ltd (NZX:BLT) is pleased to advise that it has received a written acknowledgement from Food Standards Australia New Zealand (FSANZ) that its new probiotic, BLIS M18 is not considered by the authority to be a Novel Food …From: BLIS Technologies Ltd (NZX:BLT)
Date: Thursday, 17 Jan 2013
FSANZ clears the way for BLIS M18™ probiotic use in foods
BLIS Technologies Ltd (NZX:BLT) is pleased to advise that it has received a written acknowledgement from Food Standards Australia New Zealand (‘FSANZ’) that its new probiotic, BLIS M18™ is not considered by the authority to be a Novel Food in either Australia or New Zealand. This enables the BLIS M18™ probiotic to be used directly in food applications such as yoghurt and beverages, in Australia and New Zealand bypassing the demanding and formal “novel foods” application.
By definition, a novel food is a non-traditional food that has no sufficient history of safe use and so in making this declaration, FSANZ have acknowledged the intrinsic safety of the BLIS M18™ probiotic in humans, as well as the safety of the species and the strain that BLIS M18™ originates from.
Novel food ingredients however, can be sold in Australia and New Zealand but only after they have under gone a rigorous risk and safety assessment by the researchers and food scientists within FSANZ. Once assessed and deemed to be safe, these novel foods are then added to the novel foods list, which makes up the Novel Foods Standard. Only food ingredients that appear on this list or have been assessed prior to be a non-novel food ingredient (such as the BLIS M18™ and BLIS K12® probiotics) can be legally sold as a food ingredient, in either Australia or New Zealand.
Dr Barry Richardson, CEO of BLIS Technologies said today, “We welcome the finding by the Advisory Committee on Novel Foods to indicate the ‘non-novel food’ status to BLIS M18™. This probiotic, like its partner product BLIS K12®, has an exceptional safety record and has been part of our food supply for a long time. This decision from FSANZ will now enable us to discuss the application of both these probiotics with food manufacturers who are seeking to assist with their consumer’s oral health and to fight tooth decay in children”
About BLIS M18™
BLIS M18™ is an oral cavity probiotic, which has been shown to support the teeth and gums. BLIS M18™ is able to protect itself from other invading bacteria by secreting specific short-chain proteins or peptides known as “BLIS”. BLIS stands for Bacteriocin-Like-Inhibitory- Substances and that is why BLIS probiotics are sometimes called “Next Generation, Advanced Probiotics”.